Company Filing History:
Years Active: 2006
Title: Innovations by Aaron Wilson in Genetic Research
Introduction
Aaron Wilson is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of genetic research, particularly in understanding and addressing various health conditions. With a total of 2 patents, his work focuses on the cloning of human methionine synthase reductase and its implications for health.
Latest Patents
Wilson's latest patents include groundbreaking inventions related to human methionine synthase reductase. The first patent outlines methods for evaluating the risk of, preventing, or treating neural tube defects, cardiovascular disease, cancer, and Down's syndrome. This invention features a novel gene encoding methionine synthase reductase and methods for detecting an increased likelihood of hyperhomocysteinemia. The implications of this work extend to therapeutic methods for treating and reducing the risk of these serious health conditions. The second patent similarly focuses on the cloning of the human methionine synthase reductase gene and its applications in evaluating risks associated with neural tube defects, cardiovascular disease, and cancer.
Career Highlights
Aaron Wilson is affiliated with McGill University, where he continues to advance his research in genetics. His work has garnered attention for its potential to improve health outcomes through innovative genetic solutions.
Collaborations
Wilson collaborates with esteemed colleagues such as Roy A Gravel and Rima Rozen, contributing to a rich environment of research and innovation.
Conclusion
Aaron Wilson's contributions to genetic research through his patents on human methionine synthase reductase highlight the importance of innovation in addressing critical health issues. His work exemplifies the intersection of science and technology in improving human health.